Expression, purification, immunological characterization and application of Escherichia coli-derived hepatitis C virus E2 proteins.
about
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinBlocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 EctodomainRecombinant hepatitis C virus-envelope protein 2 interactions with low-density lipoprotein/CD81 receptors.Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cellsInflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure.Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli.A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses.Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoprotein.DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBVHepatitis C virus E2 protein encapsulation into poly d, l-lactic-co-glycolide microspheres could induce mice cytotoxic T-cell response.Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.Fed-batch cultivation of Escherichia coli expressed designer hepatitis C virus diagnostic intermediate and its evaluation.
P2860
Q27333881-A197F551-7416-47EE-B936-DB3C10C4E517Q27490335-FB494F7F-CEDA-49A6-9BDF-8E4947FBCD58Q30375044-DCC5443D-C9F4-4B50-B041-405173AADCC5Q33206994-9115F494-7153-4508-BD60-7FA944BD8F1BQ34548428-D3374C61-CFB1-4AB5-A4D8-A495B52D7A89Q34605727-B3A34595-19E6-41DD-A5D6-B8A6F55734B7Q36065682-DB1396CA-1DCD-477C-AE4B-B662DAB4E257Q36308561-04D14223-7EC9-4A9C-AC57-B6CD67DB8D3EQ36308565-7C0F3F68-51A7-49B0-8FB9-C14A77254B1FQ37354264-A7E5E4D5-3CD9-42DA-9DD9-A18FC6339C21Q39046601-80379555-7A31-4D27-A970-4433361A9D5AQ42991194-6F3CBDAD-3D7E-4821-AF6B-D08E406B4F96
P2860
Expression, purification, immunological characterization and application of Escherichia coli-derived hepatitis C virus E2 proteins.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Expression, purification, immu ...... hepatitis C virus E2 proteins.
@en
type
label
Expression, purification, immu ...... hepatitis C virus E2 proteins.
@en
prefLabel
Expression, purification, immu ...... hepatitis C virus E2 proteins.
@en
P2093
P356
P1476
Expression, purification, immu ...... hepatitis C virus E2 proteins.
@en
P2093
P304
P356
10.1042/BA20010036
P577
2001-10-01T00:00:00Z